Cardinal Health Inc.
Organization details
- Legal name
- Cardinal Health Inc.
- Former names
- Cardinal Distribution Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 5122 — Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Jurisdiction of incorporation
- Ohio
- Headquarters city
- Dublin
- Headquarters state / province
- Ohio
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- CAH
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000721371
- EIN
- 31-0958666
- Wikidata ID
- Q902397
Board of directors
-
Akhil Johri · DirectorSince 2023
-
Bruce Downey · DirectorSince 2023
-
Christine Mundkur · DirectorSince 2023
-
David C. Evans · DirectorSince 2023
-
Gregory B. Kenny · DirectorSince 2023
-
Michelle Brennan · DirectorSince 2023
-
Nancy Killefer · DirectorSince 2023
-
Patricia Hemingway Hall · DirectorSince 2023
-
Robert Azelby · DirectorSince 2024
-
Robert W. Musslewhite · DirectorSince 2025
-
Sheri H. Edison · DirectorSince 2023
-
Steven Barg · DirectorSince 2023
-
Sudhakar Ramakrishna · DirectorSince 2025
-
Sujatha Chandrasekaran · DirectorSince 2023
Director election results
Annual meeting of November 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.1%
-
95.9%
-
97.0%
-
98.6%
-
99.1%
-
99.4%
-
99.4%
-
99.7%
-
99.8%
-
99.8%
-
99.8%
Board connections
13 of this board's directors also sit on 18 other boards. 6 are in the same sector.
-
ADC Therapeutics SA Same sectorvia Robert Azelby
- via Sujatha Chandrasekaran
- via Robert Azelby
-
C4 Therapeutics Inc. Same sectorvia Bruce Downey
- via Nancy Killefer
-
Charles River Laboratories International Inc. Same sectorvia Steven Barg
- via Robert W. Musslewhite
- via Robert W. Musslewhite
- via Sudhakar Ramakrishna
- via Gregory B. Kenny
- via Sujatha Chandrasekaran
-
MannKind Corporation Same sectorvia Christine Mundkur
- via Patricia Hemingway Hall
- via Nancy Killefer
-
Tango Therapeutics Inc. Same sectorvia Robert Azelby
- via Akhil Johri
- via David C. Evans
- via Sheri H. Edison
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $61,623,672
- 35 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Scherer Mary C. Officer (Chief Accounting Officer) | Open-market sale | −100 | $237.40 | $23,740 |
| Aug 19, 2026 | Scherer Mary C. Officer (Chief Accounting Officer) | Open-market sale | −2,202 | $237.39 | $522,733 |
| Aug 19, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −6,206 | $233.22 | $1,447,363 |
| Aug 19, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −3,457 | $234.29 | $809,941 |
| Aug 19, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −5,704 | $235.34 | $1,342,379 |
| Aug 19, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −6,731 | $236.46 | $1,591,612 |
| Aug 19, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −16,187 | $237.23 | $3,840,042 |
| Aug 19, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −6,244 | $237.88 | $1,485,323 |
| Aug 18, 2026 | Aaron E. Alt Officer (Chief Financial Officer) | Open-market sale | −3,115 | $234.55 | $730,623 |
| Aug 18, 2026 | Jason M. Hollar Officer (Chief Executive Officer) | Open-market sale | −21,407 | $234.56 | $5,021,226 |
| Aug 18, 2026 | Mayer Jessica L Officer (Chief Legal/Compliance Officer) | Open-market sale | −3,900 | $234.64 | $915,096 |
| Aug 18, 2026 | Mason Stephen M Officer (CEO, GMPD Segment) | Open-market sale | −3,100 | $234.59 | $727,229 |
| Aug 18, 2026 | WEITZMAN DEBORAH Officer (CEO, PSS Segment) | Open-market sale | −6,665 | $235.30 | $1,568,275 |
| Aug 18, 2026 | Michelle D. Greene Officer (Chief Information Officer) | Open-market sale | −2,500 | $234.57 | $586,425 |
| Aug 18, 2026 | Aaron E. Alt Officer (Chief Financial Officer) | Open-market sale | −12,228 | $235.54 | $2,880,183 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cardinal Health Inc.
How many directors are on Cardinal Health Inc.'s board?
Cardinal Health Inc.'s board has 14 directors: Akhil Johri, Bruce Downey, Christine Mundkur, David C. Evans, Gregory B. Kenny, Michelle Brennan, Nancy Killefer, Patricia Hemingway Hall, Robert Azelby, Robert W. Musslewhite and 4 others.
Are Cardinal Health Inc. insiders buying or selling shares?
Over the last 12 months, Cardinal Health Inc. insiders made no open-market purchases and sold $61.6 million of shares in 35 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cardinal-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.